Serina Therapeutics (SER) Asset Utilization Ratio (2019 - 2026)

Serina Therapeutics has disclosed Asset Utilization Ratio across 8 years of filings, most recently posting 0.01 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio fell 52.17% year-over-year to 0.01; the TTM figure through Jun 2026 stood at 0.01 (down 52.17% YoY), while the FY2025 annual figure was 0.02, up 166.38% from the prior year.
• Asset Utilization Ratio came in at 0.01 for Q2 2026 at Serina Therapeutics, down from 0.01 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.35 in Q3 2024 to a low of 0.01 in Q1 2025.
• Average Asset Utilization Ratio over 5 years is 0.09, with a median of 0.02 recorded in 2022.
• Year-over-year, Asset Utilization Ratio surged 2887.97% in 2024 and slumped 97.6% in 2025.
• Over 5 years, Asset Utilization Ratio stood at 0.01 in 2022, then surged by 2198.46% to 0.3 in 2023, then plunged by 97.34% to 0.01 in 2024, then surged by 69.74% to 0.01 in 2025, then tumbled by 40.9% to 0.01 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.01 in Q2 2026, 0.01 in Q4 2025, and 0.01 in Q3 2025.